|
|
Read our E-Magazine |
![]() |
Receive our E-Newsletters |
|
|
Become our Fan |
|
|
Follow Us |
A federal advisory committee has recently recommended that the name of the condition be changed from chronic fatigue syndrome (CFS) to myalgic encephalomyelitis or myalgic encephalopathy chronic fatigue syndrome (ME-CFS) to more accurately characterize the complex nature of the disease.
Chronic fatigue syndrome (CFS) is not a new disorder. In the 19th century the term neurasthenia, or nervous exhaustion, was applied to symptoms resembling CFS. In the 1930s through the 1950s, outbreaks of disease marked by prolonged fatigue were reported in the United States and many other countries. Beginning in the early to mid-1980s, interest in chronic fatigue syndrome was revived by reports in America and other countries of various outbreaks of long-term debilitating fatigue.
Recently, a federal advisory committee recommended that the Department of Health and Human Services change the name of the condition from chronic fatigue syndrome (CFS) to myalgic encephalomyelitis or myalgic encephalopathy chronic fatigue syndrome (ME-CFS). Because fatigue is just one symptom of the condition, the more scientific term ME-CFS would more accurately reflect the complex nature of the condition.
Unexplained chronic fatigue describes fatigue that lasts for more than 6 months, impairs normal activities, and has no identifiable medical or psychological problems to account for it. In addition to fatigue, people may complain of other problems, such as difficulty with memory or concentration, headaches, or sore muscles or joints.
The symptoms of CFS may be categorized as follows:
Although the exact causes of CFS are not known, researchers think infection, immune system problems, genetics, and the effects of stress on hormone production may play roles in different patients.
CFS occurs in both sexes, at all ages, and in all racial and ethnic groups. The Centers for Disease Control and Prevention (CDC) estimates that more than 1 million people in the U.S. have the disease, and millions more have similar symptoms but do not meet the full criteria for a diagnosis of CFS. Fewer than 20% of CFS patients in this country have been diagnosed, according to the CDC.
People who are in their 40s and 50s most often experience chronic fatigue. Studies have found that four out of five people with CFS are women, although women do not appear to have more severe symptoms than men with the disorder.
Children and adolescents can also have CFS, although it is less common than in adults. Most studies indicate that girls are more likely than boys to develop CFS.
Depression is very common in the general population. It affects up to one-fifth of all Americans at some point in their lives, and most depressed people feel fatigued.
The link between psychological disorders and chronic fatigue syndrome is problematic because so many of the symptoms overlap. The rates of depression are very high in CFS patients, possibly higher than in patients with other conditions (notably fibromyalgia and multiple chemical sensitivity).
Depression can lead to suicide, which may explain the increased rate of death in people with CFS. For this reason, depression should be diagnosed and treated promptly in patients with CFS.
Studies report that most children and adolescents with CFS have psychiatric disorders. Psychological factors during childhood may increase susceptibility for CFS later in life, although studies have not found any consistent association between emotional or personality disorders and CFS to explain any causal role. Some psychological factors may, however, be risk factors for CFS.
There is some evidence that stress may trigger CFS in people who are genetically at risk for the disease. People who experienced trauma during childhood -- including sexual and emotional abuse -- are significantly more likely to develop chronic fatigue syndrome than those who did not experience any trauma. Researchers say that the stress of abuse may trigger the condition through its effects on the central nervous system, immune system, and neuroendocrine system. However, many people who experience childhood trauma do not go on to develop CFS.
A number of conditions overlap or coexist with chronic fatigue syndrome and have similar symptoms. Patients with CFS may also have a diagnosis of fibromyalgia, multiple chemical sensitivity, or both. It is not clear whether these and other conditions are risk factors for CFS, are direct causes, have common causes, or have no relationship at all with CFS.
Fibromyalgia. Fibromyalgia causes prolonged fatigue and widespread muscle aches. It is the disease most often confused with CFS. The two conditions also commonly appear together. In fact, many experts believe fibromyalgia is simply another variant of chronic fatigue syndrome or they are different manifestations of the same disease. Up to 30% of children diagnosed with chronic fatigue syndrome may also have fibromyalgia.
CFS patients experience severe fatigue, whereas fibromyalgia patients experience more pain. One hypothesis is that the connection between the two conditions may be found in central sensitization, which is thought to cause fibromyalgia and may also cause CFS.
A characteristic feature of fibromyalgia is the existence of at least 11 distinct sites of deep muscle tenderness that hurt when touched firmly. The sites often include the:
Some patients with CFS exhibit similar tender pressure points. Recurrent sore throat, headache, low fever, and depression are also common symptoms of fibromyalgia. Like CFS, fibromyalgia is chronic and not curable.
Multiple Chemical Sensitivity. Multiple chemical sensitivity (MCS) is a term now used to describe a condition in which certain chemicals are believed to cause symptoms similar to CFS in some people. MCS has also been observed in people with CFS. The following proposed criteria can help recognize people with MCS:
As with CFS and fibromyalgia, there is debate as to whether MCS is a specific medical condition or is psychologically based. Everyone is exposed to many chemicals on a daily basis, and it is very difficult to determine whether chemicals are responsible for specific symptoms.
Eating Disorders. Eating disorders, notably bulimia and anorexia, have been observed in patients with CFS. The conditions often have overlapping risk factors, although it is unclear whether one causes the other.
Other Conditions that Commonly Coexist With CFS. A number of other conditions also may coexist with CFS and occur at higher-than-average rates among CFS patients:
Theories abound about the causes of chronic fatigue syndrome. No primary cause has been found that explains all cases of CFS, and no blood tests or brain scans can definitively diagnose the condition.
Convergence of Factors. A number of experts believe that CFS develops from a convergence of conditions that may include the following:
Most patients report some moderate-to-serious physical illness (such as a chronic viral infection) or emotional event (like an episode of depression) before CFS. Some experts theorize that such events, alone or in combination, may interact with certain neurologic and genetic abnormalities to trigger CFS.
Still, it is not clear what sequence of events actually leads to the fatigue and other prominent symptoms of this disorder. Nor is there any specific brain or nervous system problem that experts can point to with assurance.
Because most of the features of CFS resemble those of a lingering viral illness, many researchers have focused on the possibility that a virus or some other infectious agent causes the syndrome in some cases.
Still, not all CFS patients show signs of infection. Although experts have long been divided on whether infections play any role in this disorder, subtypes of viral-related and non-viral CFS may both exist.
Viruses. The theory that CFS has a viral cause is based on various observations that suggest an association, such as the following:
CFS has been linked with genes involved in the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These genes control response to trauma, injury, and other stressful events. Nevertheless, researchers have been unable to determine how the genetic variations influence symptoms.
A number of studies have found that there are alterations in genes involved with immune function, communication between cells, and transfer of energy to cells in people with CFS.
Researchers have identified many different genes in CFS patients that are related to blood disease, immune system function, and infection. However, no clear pattern has been found.
Abnormal levels of certain chemicals regulated in the brain system known as the hypothalamus-pituitary-adrenal (HPA) axis have been proposed as a cause of CFS. This system controls important functions, including sleep, the stress response, and depression. Of particular interest to researchers are the following chemicals and other factors controlled by the HPA axis:
It is still not clear whether any of these changes are causes of chronic fatigue syndrome, or merely findings in some patients.
CFS has sometimes been referred to as the "chronic fatigue immune dysfunction syndrome." A number of studies have found many irregularities of the immune system. Some components appear to be over-reactive, while others appear to be under-reactive, but no consistent picture has emerged to explain CFS as a disease of the immune system.
Allergies. Some studies have reported that a majority of CFS patients have allergies to foods, pollen, metals (such as nickel or mercury), or other substances. One theory is that allergens, like viral infections, may trigger a cascade of immune abnormalities that lead to CFS. However, most allergic people do not have CFS.
Autoimmune Abnormalities. The risk profile for chronic fatigue syndrome is similar to the risk profiles for a number of autoimmune diseases. Studies are inconsistent, however, in reporting the presence of autoantibodies (antibodies that attack the body's own tissues) in CFS, and the disease is unlikely to be due to autoimmunity.
Studies have observed that some patients who fit the strict criteria for chronic fatigue syndrome also have symptoms of a condition known as neurally mediated hypotension (NMH). NMH causes a dramatic drop in blood pressure when a person stands up, even for as little as 10 minutes. Its immediate effects can be light-headedness, nausea, and fainting. However, studies have reported no higher incidence of NMH in chronic fatigue patients.
Psychological, personality, and social factors are strongly associated with chronic fatigue in most patients. The complex relationship between physical and emotional factors has yet to be fully understood, however. Studies have not found any consistent association between emotional or personality disorders and CFS. Psychological factors, then, are unlikely to be a primary cause of CFS. However, they may play a role in increasing susceptibility to the disorder. In many cases, CFS promotes psychological and social dysfunction.
It is very difficult to diagnose chronic fatigue syndrome. Even experts do not have a clear definition of what chronic fatigue actually is, or what mechanisms in the brain or nervous system are responsible for it. The best diagnostic approach is to determine whether the patient matches the criteria for CFS and rule out other possible causes of symptoms.
In May 2006, the Centers for Disease Control and Prevention (CDC) released a revised definition for Chronic Fatigue Syndrome based on a consensus of many of the leading CFS researchers and doctors (including input from patient group representatives). In the revised definition, chronic fatigue syndrome is considered a subset of chronic fatigue, a broader category defined as unexplained fatigue that lasts for 6 months or longer. Chronic fatigue is considered a subset of prolonged fatigue, which is defined as fatigue that lasts for 1 month or more.
Unexplained chronic fatigue can be classified as CFS if the patient meets the following criteria:
In 2007, the British National Institute for Health and Clinical Excellence (NICE) released new guidelines for the diagnosis and management of CFS in adults and children. According to these guidelines, CFS may be diagnosed if the person has disabling fatigue that starts suddenly, lasts a long time, keeps coming back, and can't be explained by another condition.
People with CFS also can have the following symptoms:
After ruling out other possible causes, the doctor should consider a diagnosis of CFS if symptoms have lasted for 4 months in adults or 3 months in children. Children should be diagnosed by a pediatrician.
A doctor should first take a careful personal and family medical history (which may include a psychological profile), and perform a thorough physical examination. Patients should be prepared to answer questions such as:
The doctor may also ask about any changes in weight, or request that a patient monitor his or her morning and afternoon body temperatures. Patients should report any drugs they are taking, including vitamins and over-the-counter or herbal medications.
Standard tests are typically recommended to rule out specific conditions that can cause persistent fatigue. These tests include:
No one blood, urine, or other laboratory test can diagnose CFS. If any test is abnormal, it is not useful for diagnosing CFS specifically, and the doctor should look for other causes of these abnormalities.
That said, research has found that certain components in urine are unique in people with CFS, and may someday be considered biomarkers of the disease. Additionally, antibodies to Epstein-Barr virus, increased levels of isoprostanes, and decreased levels of alpha-tocopherol (vitamin E) -- markers of oxidative stress -- have been found in the blood of some people with CFS.
Among the many other common conditions that can lead to feelings of temporary exhaustion are the following:
In most of these cases, fatigue can be relieved with adequate rest. It is important to note that longstanding fatigue can be a sign of a serious medical or psychological problem. A number of more serious conditions may cause persistent fatigue and other symptoms of CFS, and should be ruled out. Patients and doctors should not overlook these diseases, even if the conditions have been previously treated, because they may not have completely gotten better or they may cause residual fatigue. Doctors can usually distinguish these diseases from CFS after a clinical evaluation and laboratory tests.
Infectious Mononucleosis and Epstein-Barr Virus. Infectious mononucleosis is marked by fatigue and swollen glands. It primarily affects adolescents and young adults. Research finds that fatigue may last for a year or more in a small percentage of adolescents who have had mononucleosis. Females, and those with more severe fatigue, are more likely to develop chronic fatigue syndrome. Blood tests can detect the Epstein-Barr virus (EBV), which causes mononucleosis.
Autoimmune Diseases. Some diseases, including systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis are caused by autoimmunity, a condition in which the person's immune system attacks the body's own tissues. The early symptoms of these conditions may mimic some CFS symptoms, such as muscle and joint pain and fatigue. These diseases, like CFS, also occur more often in women than in men. Most of these conditions can be confirmed with laboratory or x-ray/radiologic tests. However, some autoimmune diseases may develop slowly. Doctors should keep track of any changes in symptoms over time to rule out these serious illnesses.
Post-Lyme Disease Syndrome. Rarely, patients treated for Lyme disease continue to have nonspecific symptoms, which can last for years after antibiotic treatment and can resemble symptoms of chronic fatigue syndrome. It is not clear whether these symptoms are caused by Lyme disease itself.
Depression and Severe Mental Disorders. The Centers for Disease Control (CDC), which established the definitions for chronic fatigue syndrome, recognizes depression as one of the symptoms of CFS. In one study, 36% of CFS patients were depressed. Depression in these patients was associated with lower self-esteem and an increased likelihood of suicidal thoughts. However, according to the CDC, anyone with major depression or other severe psychiatric disorders, including bipolar disorder and schizophrenia, does not meet the criteria for chronic fatigue syndrome.
Symptoms of major depression include the following:
Major depression is likely if a person has several of these symptoms and no physical symptoms (such as sore throat, aches and pains, or fever). The longer fatigue has continued without physical symptoms, the more likely that the diagnosis is depression.
A persistent form of minor depression called dysthymia may be more difficult to differentiate from CFS and may actually account for a subset of CFS cases. Dysthymia has many of the same symptoms as major depression, but these symptoms are less intense and last much longer -- at least 2 years. The symptoms of dysthymia have been described as a "veil of sadness" that covers most activities.
Patients with depression generally perceive their illnesses differently than people with CFS:
Many previously healthy patients with CFS become depressed and anxious because they feel so exhausted all the time. CFS may also lead to highly stressful socioeconomic situations, such as social isolation and poverty. These situations can contribute to, and even cause emotional disorders in susceptible individuals, which can worsen CFS.
Sleep Disturbances. Certain sleep disorders may cause persistent fatigue and can be confused with CFS:
Researchers have found that people with CFS have altered amounts of slow wave sleep, which could indicate a problem with sleep regulation. Non-restorative sleep and nighttime restlessness are the most common complaints of people with CFS.
Conditions that Cause Joint Pain, Muscle Aches, or Both. A number of illnesses cause one or more CFS symptoms, including arthritic symptoms, fever, and fatigue.
Severe Obesity. People who are severely obese often have symptoms of chronic fatigue because of the stress imposed by their weight. People who are obese are also at higher risk for sleep apnea, which can confuse the diagnosis.
Other Medical Conditions that Usually Rule Out CFS. Many diseases, both minor and serious, can cause prolonged or chronic fatigue, including:
Drugs and Alcohol. Fatigue is a side effect of many prescription and over-the-counter medications, such as antihistamines. In addition, dependency on or abuse of alcohol or illicit drugs may lead to chronic fatigue. Medications should be considered as a possible cause of fatigue if an individual has recently started, stopped, or changed medicines. Withdrawal from caffeine can produce depression, fatigue, and headache.
The physical severity of chronic fatigue syndrome varies. Most commonly, patients with CFS report that they have trouble fulfilling both home and work responsibilities.
Many CFS sufferers cannot work more than part-time. In unusual cases, patients are severely disabled and even bedridden. They are unable to do even the simplest tasks, such as light housework.
Patients with CFS are more likely to lose their jobs, possessions, and support from friends and family than are people who have other conditions that cause fatigue.
Most patients say that while fatigue is the most incapacitating symptom, mental impairment, such as an inability to concentrate or remember, is the most distressing symptom. The effects of CFS on mental functioning are complex. Some experts believe that the impaired mental functioning is due to depression, which is common in CFS patients.
Although general intelligence is not impaired, CFS patients may test lower in certain mental functions, particularly speed and efficiency in processing complex information, and many may also have memory impairments. This impaired mental function may occur, even if the person does not have depression or other psychiatric disorders.
Because the illness remains elusive and poorly defined, and there are few objective measures for recovery, experts have found it difficult to determine the long-term course of the disease. Although some studies have reported that more than half of patients who complain of chronic fatigue are still fatigued at 2 years, with long-term, consistent treatment, many patients can improve and even make a real recovery.
Although CFS itself is not fatal, suicide can be a real risk. Continuing, long-term treatment for CFS and depression can help reduce this risk.
Although children with symptoms of chronic fatigue have not been as rigorously studied as adults, limited evidence suggests that CFS can be significantly disabling in young people. Studies report that adolescents who meet the criteria for CFS experience anxiety, depression, and school absenteeism. Children with CFS may have more difficulty than usual paying attention and remembering, which may explain why these kids have more trouble in school than their peers.
Still, some studies indicate that children have a better prognosis than adults and most will recover after 1 - 4 years. Several studies have indicated that cognitive-behavioral therapy is an effective treatment for adolescents with CFS.
There is no proven or reliable cure for CFS, and no drug has been developed specifically for this disorder. Because CFS remains poorly understood, many patients have problems finding good care. Overall, the recommended strategy for treatment includes a combination of the following:
Patients who stay as active as possible and try to have some control over the course of the disorder have the best chance for improvement. It is important for patients to choose physicians who are willing to consider the problem a medical condition with psychiatric components. They should be very wary, however, if the physician recommends excessive and expensive treatments that may have serious side effects and that have no proven benefits. For patients with severe CFS that cannot be managed with lifestyle changes and standard medications, asking the physician about enrolling in any available clinical trials may be helpful.
Cognitive-Behavioral Therapy
CBT is designed to help CFS patients regain a sense of control, and is proving to have substantial benefits for some patients. Some experts believe that patients who are diagnosed with CFS should be referred to therapists who are trained in cognitive-behavioral therapy. (Psychoanalysis and other interpersonal psychological therapies, which are concerned with subconscious thoughts and early childhood memories, are not generally helpful for CFS patients.)
The Goals of Cognitive-Behavioral Therapy. The primary goals of cognitive-behavioral therapy (referred to below as just cognitive therapy) are to change any distorted perceptions that individuals have of the world and of themselves, and to change their behavior accordingly. For CFS patients, this means learning to think differently about their fatigue, improving their ability to deal with stressful situations, and managing their disorder. CBT can also help people manage their sleep problems and find the appropriate activity levels for them. Cognitive therapy is particularly helpful for defining and setting limits, behaviors that are extremely important for CFS patients.
The Procedure. CBT is usually performed over 6 - 20 sessions, each lasting about an hour. Patients are also given homework, which usually includes keeping a diary and attempting tasks that they have avoided because of previous negative attitudes.
A typical cognitive therapy program may involve the following measures:
Using both self-observation and specific tasks, patients gradually shift their fixed ideas that they are helpless against the fatigue that dominates their lives. They move to the perception that fatigue is only one negative experience among many positive ones.
Success Rates. One review of CFS trials reported that, of all therapies available to CFS patients, only cognitive behavioral therapy (CBT) and graded exercise showed conclusive benefits. CBT is effective at reducing the symptoms of fatigue, and it appears to be more effective than other psychological therapies. Although CBT doesn't bring patients completely back to normal, research has found that people who use the therapy have higher mental health scores, and are able to walk faster and with less fatigue than those who do not use CBT. Cognitive therapy may also be an effective treatment for adolescents with CFS. Young patients who receive CBT report improvements in fatigue, functional status, and school attendance.
Not all studies support the benefits of cognitive therapy for CFS. It is important to note that different therapists may have different assumptions about CBT and may use different techniques. For instance, some therapists believe that CFS is a purely psychological problem and that patients must reject the notion of physical causes, abandon all reliance on assistive devices, and participate in challenging exercise programs. Other therapists do not attempt to change patients' underlying beliefs, but instead focus on helping patients conserve energy and better cope with the limitations of their illness. When considering CBT, patients and their families must be aware of such important differences in therapists.
The power of the mind to improve health problems is significant, and treatments that promote a positive outlook are beneficial for any disease.
A number of studies have suggested that a graded exercise program, in which patients perform increasingly more intense levels of exercise tailored to their individual abilities, has benefits for many patients with CFS. Exercise is best performed in combination with cognitive behavioral therapy.
Reports have found that most CFS patients who are able to engage in exercise, particularly aerobic exercise, report less fatigue and better daily functioning and fitness. Exercise therapy can be beneficial for CFS, particularly when combined with patient education.
Graded exercise may not work for all patients with CFS, however. Many CFS patients have severe conditions, and some are very incapacitated (such as being wheelchair bound). These patients are unlikely to be able to do graded exercise. All CFS patients have a lower exercise capacity than healthy individuals, and over-exercising can intensify symptoms. Some patients experience profound fatigue following even modest exercise. It is the primary reason for the low activity levels in these patients.
The following tips may be helpful for CFS patients when embarking on an exercise program:
Work with your health care provider to find a level of activity you can handle. Then gradually increase your activity level. Activity management should involve:
Although there is no evidence to support any specific dietary factors in CFS, patients should be sure to maintain a healthy diet that includes:
Stress Reduction Techniques. One panel of experts concluded that relaxation and stress-reduction techniques were helpful in managing chronic pain. These techniques also can help relieve the stress associated with the disease. They are not useful, however, as the primary treatment for CFS. A number of relaxation techniques are available, including:
Supportive Family and Groups. Having strong, supportive relationships with family and friends can help CFS patients get better. However, CFS patients should try not to impose unreasonable expectations on loved ones. Attending support groups with fellow patients may be very helpful. In one study, sharing experiences in a group therapy setting proved to be the most valuable component in treatment, and it improved patients' coping abilities.
No medications are specifically approved to treat CFS. However, some medications may be useful for pain or other symptoms, or in cases in which CFS has a specific medical cause. Doctors generally use combinations of drugs to accomplish specific goals, such as medication at night to improve sleep and medication in the morning to improve cognition and energy. Treatment is very individualized.
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Patients with CFS may benefit from using NSAIDs -- common pain relievers that reduce pain and inflammation. Types of NSAIDs include aspirin, ibuprofen (Motrin, Advil, Nuprin), and naproxen (Aleve, Naprosyn, Naprelan, Anaprox).
Patients should use only the lowest effective dose, because high dosages of NSAIDs can cause heart problems (such as increased blood pressure and risk of heart attack), kidney problems, and stomach bleeding. Patients who are at increased risk for stomach bleeding and ulcers should either switch to another type of pain reliever, or take the NSAID along with a proton-pump inhibitor drug, such as omeprazole (Prilosec) or esomeprazole (Nexium), or with misoprostol (Cytotec). (Misoprostol can cause miscarriage and should not be used by women who may be pregnant.)
People with high blood pressure, severe circulation disorders, or kidney or liver problems, as well as people taking diuretics or oral hypoglycemics must be closely monitored if they need to use NSAIDs on a long-term basis. Because NSAIDs reduce blood clotting, NSAID users who are scheduled for surgery should stop taking these drugs a week before the operation. Other side effects of NSAIDs include:
COX-2 Inhibitors (Coxibs). Coxibs inhibit an inflammation-promoting enzyme called COX-2. This drug class was initially thought to provide benefits equal to those of NSAIDs while causing less gastrointestinal distress. However, following numerous reports of cardiovascular events, as well as skin rashes and other adverse effects, two COX-2 inhibitors were withdrawn from the market. Celecoxib (Celebrex) is still available, but it must be used with great care. Patients should discuss with their doctors whether this drug is appropriate and safe for them.
Because of the association between depression and CFS, patients often try antidepressants, with varying degrees of success. Common side effects of many antidepressants include:
Virtually all antidepressants have complicated interactions with other drugs, and some of these interactions are very serious.
Tricyclic Antidepressants. Antidepressants known as tricyclics affect brain chemicals that are involved in managing pain. These medications may be particularly helpful for CFS patients. For example, the tricyclic amitriptyline (Elavil) is known to relieve many CFS symptoms, including sleeplessness and low energy levels. These drugs may provide benefits by promoting deep sleep and inhibiting pain pathways in the nervous system. Symptom improvement can take 3 - 4 weeks. Other tricyclics include doxepin (Sinequan), desipramine (Norpramin), nortriptyline (Pamelor), clomipramine (Anafranil), and imipramine (Tofranil, Janimine). Patients with CFS normally respond to much lower doses than those used to treat people with depression. In fact, many CFS patients cannot tolerate the higher doses commonly used to treat depression. As with all medications, tricyclics must be taken as directed. An overdose can be life-threatening. Tricyclics should not be taken together with SSRIs, because of the possibility of dangerous side effects.
Other Antidepressants. Other antidepressants, including bupropion (Wellbutrin), nefazodone (Serzone), or mirtazapine (Remeron), affect combinations of different neurotransmitters, and some may have moderate benefits for CFS patients. For example, in one study, nefazodone improved mood, fatigue, and sleep disturbances.
SSRIs. The popular antidepressants known as selective serotonin-reuptake inhibitors (SSRIs) may be helpful for CFS patients who experience significant depression. These drugs include fluoxetine (Prozac), sertraline (Zoloft), and paroxetine (Paxil). Cymbalta (duloxetine) is a new antidepressant that is classified as a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) because it affects both neurotransmitters.
Psychostimulants. Psychostimulants may be helpful for patients with CFS who also have cognitive problems, such as difficulty concentrating, memory problems, and other attention deficit hyperactivity disorder (ADHD)-like characteristics. Psychostimulants include Dexamphetamine, Adderall, methylphenidate (Ritalin) and Ritalin-like drugs such as Focalin, Concerta, Ritalin LA, and Metadate.
Strattera and Provigil are two other drugs that have been evaluated for the treatment of fatigue, but they have not been well studied.
Because of the difficulties in treating chronic fatigue syndrome, many patients seek alternative therapies. Some of these therapies, such as acupuncture, yoga, and relaxation techniques, may be helpful and are not dangerous. No scientific evidence exists that vitamin and mineral supplements will relieve CFS, but some people do report that they find supplements helpful.
Herbal and Dietary Supplements. Popular herbal and dietary supplements for CFS include coenzyme Q10, vitamin B12, vitamin C, magnesium, multivitamins, DHEA, ginseng, and acetylcarnitine. Some herbs, such as St. John's wort, ginkgo, and comfrey, may cause serious side effects and drug interactions. To date, these herbs haven't been well studied in carefully controlled clinical trials. More research is needed to determine whether any herbs can actually benefit patients with CFS.
Herbal remedies and dietary supplements are not regulated by the FDA. This means that manufacturers and distributors do not need FDA approval to sell their products. In addition, any substance that can affect the body's chemistry can, like any drug, produce side effects that may be harmful. There have been a number of reported cases of serious and even lethal side effects from herbal products.
Some so-called natural remedies have been found to contain standard prescription medication. Of specific concern are studies suggesting that up to 30% of herbal remedies imported from China have been laced with potent pharmaceuticals, such as phenacetin and steroids. Most reported problems occur in herbal remedies imported from Asia. One study reported that a significant percentage of such remedies contain toxic metals.
The concentration of the active ingredient in many of these remedies may not always match what is claimed on the label.
CFS patients should be wary of the following remedies:
Other alternative remedies with no proven benefit and possible toxic and dangerous side effects include:
Adams D, Wu T, Yang X, Tai S, Vohra S. Traditional Chinese herbs for the treatment of idiopathic chronic fatigue and chronic fatigue syndrome. Cochrane Database Syst Rev. 2009(4):CD006348.
Buskila D. Pediatric fibromyalgia. Rheum Dis Clin North Am. 2009;35(2):253-261.
Engleberg NC. Chronic fatigue syndrome. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2009:chap 131.
Fuller-Thomson E, Nimigon J. Factors associated with depression among individuals with chronic fatigue syndrome: findings from a nationally representative survey. Fam Pract. 2008;25:414-422.
Goldman L, Ausiello D. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier, 2007.
Haig-Ferguson A, Tucker P, Eaton N, Hunt L, Crawley E. Memory and attention problems in children with CFS/ME. Arch Dis Child. 2008 Nov 11 [Epub ahead of print].
Heim C, Nater UM, Maloney E, Boneva R, Jones JF, Reeves WC. Childhood trauma and risk for chornic fatigue syndrome: association with neuroendocrine dysfunction. Arch Gen Psychiatry; 2009:66(1):72-80.
Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics. 2009;124(1):189-193.
Kerr JR. Gene profiling of patients with chronic fatigue syndrome/myalgic encephalomyelitis. Curr Rheumatol Rep. 2008;10:482-491.
Knoop H, Stulemeijer M, de Jong LW, Fiselier TJ, Bleijenberg G. Efficacy of cognitive behavioral therapy for adolescents with chronic fatigue syndrome: long-term follow-up of a randomized, controlled trial. Pediatrics. 2008;121:e619-e625.
Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science. 2009;326(5952):585-589.
Price JR, Mitchell E, Tidy E, Hunot V. Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database Syst Rev. July 2008(3):CD001027.
Santhouse A, Hotopf M, David AS. Chronic fatigue syndrome. BMJ. 2010;340:c738.